Johns Hopkins HIV Guide
Gatifloxacin
INDICATIONS
FDA
FDA
- No longer available in the U.S. as an injectable or oral tablet.
- Bacterial conjunctivitis (ophthalmic solution)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Acute bacterial sinusitis
- Community-acquired pneumonia
- Acute bacterial exacerbation of chronic bronchitis
- Uncomplicated and complicated urinary tract infection
- Uncomplicated urethral and cervical gonorrhea and acute uncomplicated rectal infections in women
- Uncomplicated skin and skin structure infections
- Treatment of TB, including MDR-TB in combination with other agents
- Bacterial keratitis (ophthalmic solution)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: August 18, 2023
Citation
Auwaerter, Paul G, and Edina Avdic. "Gatifloxacin." Johns Hopkins HIV Guide, 2023. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545267/7/Gatifloxacin.
Auwaerter PG, Avdic E. Gatifloxacin. Johns Hopkins HIV Guide. 2023. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545267/7/Gatifloxacin. Accessed September 21, 2023.
Auwaerter, P. G., & Avdic, E. (2023). Gatifloxacin. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545267/7/Gatifloxacin
Auwaerter PG, Avdic E. Gatifloxacin [Internet]. In: Johns Hopkins HIV Guide. ; 2023. [cited 2023 September 21]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545267/7/Gatifloxacin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Gatifloxacin
ID - 545267
A1 - Auwaerter,Paul,M.D.
AU - Avdic,Edina,Pharm.D.
Y1 - 2023/08/18/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545267/7/Gatifloxacin
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
